T, v. G., RB, H., L, L., & N, S. (2022). Voclosporin: A novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 37(5), 917. https://doi.org/10.1093/ndt/gfab022
Chicago Style (17th ed.) CitationT, van Gelder, Huizinga RB, Lisk L, and Solomons N. "Voclosporin: A Novel Calcineurin Inhibitor with No Impact on Mycophenolic Acid Levels in Patients with SLE." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association 37, no. 5 (2022): 917. https://doi.org/10.1093/ndt/gfab022.
MLA (9th ed.) CitationT, van Gelder, et al. "Voclosporin: A Novel Calcineurin Inhibitor with No Impact on Mycophenolic Acid Levels in Patients with SLE." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, vol. 37, no. 5, 2022, p. 917, https://doi.org/10.1093/ndt/gfab022.